Ann Nutr Metab
The relationship between the gutbrainsleep axis and hormonal regulation helps explain why GLP-1 signaling capacity can vary significantly across individuals, even those with similar microbial profiles
Doses cant be guaranteed, and they may be mixed with other ingredients that may lead to adverse effects, Isaacs says
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
Mounjaro/Zepbound (tirzepatide), approved dual GLP-1/GIP agonist for type 2 diabetes and obesity Recent Highlights: In April 2026, the FDA approved orforglipron (Foundayo), making it one of the first oral GLP-1 pills that can be taken any time of day and that has no food or water restrictions
Its also worth noting that the oral drugs in the kits have been shown to produce more modest weight loss results compared to the Wegovy pill and Foundayo , which are FDA-approved pills specifically for weight loss